Piramal Pharma Faces US Lawsuit from VetDC Inc - $8.91 Million Damages
By Rediff Money Desk, NEWDELHI Nov 30, 2023 20:53
Piramal Pharma Solutions Inc, a subsidiary of Piramal Pharma, is facing a civil suit from VetDC Inc seeking $8.91 million in damages for alleged breaches in a supply agreement. The lawsuit concerns contaminated products manufactured and supplied by PPS between 2018 and 2019.
New Delhi, Nov 30 (PTI) Piramal Pharma Ltd on Thursday said VetDC Inc, an erstwhile partner, has filed a civil suit against its wholly-owned arm Piramal Pharma Solutions Inc seeking damages of up to USD 8.91 million (nearly Rs 75 crore) in a court in the US.
Piramal Pharma Solutions Inc (PPS) and VetDC had entered into a supply agreement in 2018 under which PPS manufactured and supplied certain products to VetDC. This agreement expired in December 2021, Piramal Pharma said in a regulatory filing.
"VetDC has initiated a civil suit on November 28, 2023 making certain claims in relation to batches of the product manufactured and supplied during 2018-2019 which were rejected or partially rejected due to contamination," it added.
The suit has been filed before the District Court for the Eastern District of Kentucky, USA.
Further, VetDC also claims that it has suffered losses due to breach of contract.
"VetDC has alleged that it has suffered damages to the extent of USD 8.91 million approximately under various counts in this civil suit. VetDC has sought actual damages, costs expended, pre and post judgment interest and reasonable attorney fees as reliefs in this civil suit," the filing said.
"We believe that VetDC claims are incorrect and/or are without adequate legal basis. PPS will be addressing this civil suit within the designated time," Piramal Pharma said.
Piramal Pharma Solutions Inc (PPS) and VetDC had entered into a supply agreement in 2018 under which PPS manufactured and supplied certain products to VetDC. This agreement expired in December 2021, Piramal Pharma said in a regulatory filing.
"VetDC has initiated a civil suit on November 28, 2023 making certain claims in relation to batches of the product manufactured and supplied during 2018-2019 which were rejected or partially rejected due to contamination," it added.
The suit has been filed before the District Court for the Eastern District of Kentucky, USA.
Further, VetDC also claims that it has suffered losses due to breach of contract.
"VetDC has alleged that it has suffered damages to the extent of USD 8.91 million approximately under various counts in this civil suit. VetDC has sought actual damages, costs expended, pre and post judgment interest and reasonable attorney fees as reliefs in this civil suit," the filing said.
"We believe that VetDC claims are incorrect and/or are without adequate legal basis. PPS will be addressing this civil suit within the designated time," Piramal Pharma said.
Read More On:
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- ARC Finance
- 1.51 (+ 2.72)
- 99106131
- Vodafone Idea L
- 8.27 (+ 1.72)
- 37910491
- Guj. Toolroom Lt
- 18.98 (+ 4.98)
- 33052379
- Srestha Finvest
- 0.81 ( -2.41)
- 24087791
- Filatex Fashions
- 0.69 ( -4.17)
- 20455844
MORE NEWS
CCI Clears Coal India in E-Auction Scheme Case
India's competition watchdog CCI dismissed a complaint against Coal India's e-auction...
HDFC Bank Loan Growth Rises 3% in Q3
HDFC Bank reports a 3% increase in loan growth in the December quarter, reaching Rs...
IDBI Bank Reports 18% Loan Growth in Q3
IDBI Bank saw an 18% increase in loan growth during the December quarter, reaching Rs...